© Reuters. Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday
Benzinga – by Avi Kapoor, Benzinga Staff Writer.
U.S. shares traded larger, with the Dow Jones index gaining round 50 factors on Tuesday.
Shares of Blue Bird Corporation (NASDAQ: BLBD) shares rose sharply throughout Tuesday’s session after the corporate reported better-than-expected monetary outcomes for its fourth quarter and elevated its FY24 income forecast.
Blue Bird reported quarterly earnings of 66 cents per share, exceeding the analyst expectations of 48 cents. Revenue clocked in at $302.96 million which beat the analyst consensus estimate of $290.11 million.
Blue Bird shares gained 9.1% to $23.80 on Tuesday.
Here are another large shares recording good points in as we speak’s session.
- Icosavax, Inc. (NASDAQ: ICVX) rose jumped 47.1% to $15.43 after AstraZeneca introduced plans to purchase Icosavax in a deal valued at as much as $1.1 billion. Concurrently, Icosavax launched topline interim outcomes for its Phase 2 research of IVX-A12, a mixture virus-like particle (VLP) vaccine candidate concentrating on each respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
- Gaotu Techedu Inc. (NYSE: GOTU) gained 18% to $3.4650.
- Intchains Group Limited (NYSE: ICG) rose 13.5% to $10.16.
- Oil-Dri Corporation of America (NYSE: ODC) jumped 12.2% to $66.09 following first-quarter outcomes.
- Bitfarms Ltd. (NASDAQ: BITF) gained 9.9% to $2.4950.
- CAVA Group, Inc. (NYSE: CAVA) rose 9.8% to $35.68.
- Cassava Sciences, Inc. (NASDAQ: SAVA) gained 9.4% to $30.32.
- Eagle Bulk Shipping Inc. (NYSE: EGLE) climbed 9.2% to $50.42. Star Bulk and Eagle Bulk Shipping introduced plans to mix.
- Innoviz Technologies Ltd. (NASDAQ: INVZ) rose 8.6% to $2.49.
- MorphoSys AG (NASDAQ: MOR) surged 8.6% to $9.59. MorphoSys not too long ago introduced outcomes from the Phase 3 MANIFEST-2 research investigating pelabresib together with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve sufferers with myelofibrosis.
- Digital Turbine, Inc. (NASDAQ: APPS) rose 7.8% to $6.58.
- Disc Medicine, Inc. (NASDAQ: IRON) gained 7.8% to $65.84. Disc introduced up to date outcomes from Phase 2 BEACON research of bitopertin and different packages on the sixty fifth ASH Annual Meeting.
- BRP Group, Inc. (NASDAQ: BRP) rose 7% to $20.74. Raymond James upgraded BRP Group from Outperform to Strong Buy and introduced a $30 worth goal.
- MoneyLion Inc. (NYSE: ML) gained 6.4% to $44.41.
Now Read This: Bitcoin, Ethereum Record Losses; FTX Token Becomes Top Loser
© 2023 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
